RESEARCH / DISCOVERY
← Back to the library

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease.

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease.

Read the original publication

Where did the research take place?

The study site has not been established. Author addresses may differ from where the research occurred.

Toulouse, FR · Author affiliation

Department of Clinical Pharmacology and Neurosciences, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), French NS Park/F-CRIN Network, University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France.
Location evidence

Limoges, FR · Author affiliation

Department of Neurology, Limoges University Hospital, Inserm, U1094, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France.
Location evidence

Explore research worldwide

A plain-language reading has not been prepared for this paper yet.

Explore another example or bring your own paper

Pasted text and PDF extraction stay on this computer. The local guide explains terms and surfaces passages; rewriting requires a configured local model. Scanned PDFs need OCR first.

RECORD & PROVENANCE